Retrieve available abstracts of 12 articles: HTML format
Single Articles
May 2025
WANG H, Wang N Letter Re: Induction chemotherapy followed by chemoradiation in locally advanced
cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial.
Eur J Cancer. 2025 May 19:115515. doi: 10.1016/j.ejca.2025.115515. PubMed
April 2025
ONAL C, Elmali A, Demirhan B, Guler OC, et al Letter comments on: "Induction chemotherapy followed by chemoradiation in locally
advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial".
Eur J Cancer. 2025 Apr 22:115448. doi: 10.1016/j.ejca.2025.115448. PubMed
EMINOWICZ G, Vaja S, Hackshaw A, McCormack M, et al Response to letter Re: Induction chemotherapy followed by chemoradiation in
locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE
trial.
Eur J Cancer. 2025 Apr 22:115449. doi: 10.1016/j.ejca.2025.115449. PubMed
March 2025
EMINOWICZ G, Vaja S, Gallardo D, Kent C, et al Induction chemotherapy followed by chemoradiation in locally advanced cervical
cancer: Quality of life outcomes of the GCIG INTERLACE trial.
Eur J Cancer. 2025;220:115375. PubMedAbstract available
February 2025
HASEGAWA K, Nishio S, Yamamoto K, Fujiwara H, et al Tegafur-uracil maintenance chemotherapy post-chemoradiotherapy for cervical
cancer: Randomized trial.
Eur J Cancer. 2025;219:115304. PubMedAbstract available
January 2025
OAKNIN A, Monk BJ, de Melo AC, Kim HS, et al Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in
the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial.
Eur J Cancer. 2025;216:115146. PubMedAbstract available
October 2024
WENZEL HHB, Schnack TH, Van der Aa MA, Jensen PT, et al Risk factors for lymph node metastasis in women with FIGO 2018 IA cervical cancer
with a horizontal spread of > 7 mm.
Eur J Cancer. 2024;212:115063. PubMedAbstract available
September 2024
BIZZARRI N, Querleu D, Ramirez PT, Dostalek L, et al Survival associated with the use of sentinel lymph node in addition to
lymphadenectomy in early-stage cervical cancer treated with surgery alone: A
sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study.
Eur J Cancer. 2024;211:114310. PubMedAbstract available
March 2024
TUNINETTI V, Virano E, Salutari V, Ricotti A, et al Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a
nominal use program in Italy: The MITO 44 study.
Eur J Cancer. 2024;203:114039. PubMedAbstract available
February 2024
TANAKA LF, Schoffer O, Schriefer D, Schauberger G, et al An audit of 1632 routinely collected cervical cancer screening smears from 398
women in Germany: Results from the TeQaZ Study.
Eur J Cancer. 2024;201:113915. PubMedAbstract available
August 2023
DING S, Li H Re: A federated approach to identify women with early-stage cervical cancer at
low risk of lymph node metastases.
Eur J Cancer. 2023 Aug 1:112978. doi: 10.1016/j.ejca.2023.112978. PubMed
February 2023
WENZEL HHB, Hardie AN, Moncada-Torres A, Hogdall CK, et al A federated approach to identify women with early-stage cervical cancer at low
risk of lymph node metastases.
Eur J Cancer. 2023;185:61-68. PubMedAbstract available